2016 Annual Meeting | HeadTalks: Do the AAN Guidelines Advance Neurologic Care?
| No timeline events available at this time. |
| Cynthia L. Harden, MD | Dr. Harden has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Dr. Harden has stock in Xenon Pharmaceuticals Inc.. Dr. Harden has received intellectual property interests from a discovery or technology relating to health care. |